Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease
Cascinu S, Cordella L, ferro E et al
7 Key Performance Indicators: Average Weight Loss: Participants lost an average of 4.9 kg by the trial endpoint
A higher-dose option is also available (10mg BPC-157, 10mg TB-500, 50mg GHK-Cu) for studies requiring increased peptide concentrations
At Cymbiotika, we believe that informed choices are the foundation of a healthy routine
Chantel Kennaugh, head of public sector and nutrition, GB for Worldpanel by Numerator, said: What was once a specialised treatment, primarily prescribed for type 2 diabetes, has in just a few short years become a mainstream force